|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.750 USD | 0.00% |
|
-8.94% | -73.57% |
| 05-18 | ISpecimen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-10 | ISpecimen Inc. announced that it has received $2.500004 million in funding | CI |
Company Valuation: iSpecimen Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Market Cap 1 | 68.07 | 12.26 | 4.543 | 2.556 | 2.541 |
| Change | - | -81.98% | -62.95% | -43.74% | -0.56% |
| Enterprise Value (EV) 1 | 43.75 | -2.86 | -0.2663 | 0.9895 | -4.071 |
| Change | - | -106.54% | 90.69% | 471.55% | -511.4% |
| P/E Ratio | - | -1.19x | -0.41x | -0.15x | -0.11x |
| PBR | 2.29x | 0.6x | 0.47x | 1.36x | 0.71x |
| PEG | - | - | -0.07x | 0x | 0x |
| Capitalization / Revenue | 6.11x | 1.18x | 0.46x | 0.28x | 1.32x |
| EV / Revenue | 3.93x | -0.27x | -0.03x | 0.11x | -2.11x |
| EV / EBITDA | -7.44x | 0.28x | 0.02x | -0.08x | 0.47x |
| EV / EBIT | -7.38x | 0.28x | 0.02x | -0.08x | 0.45x |
| EV / FCF | -3.36x | 0.54x | 0.04x | -0.2x | 1.46x |
| FCF Yield | -29.8% | 185% | 2,404% | -494% | 68.4% |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | - | -926.8 | -984 | -703.3 | -91.15 |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | 11.14 | 10.4 | 9.928 | 9.291 | 1.929 |
| EBITDA 1 | -5.88 | -10.16 | -11 | -12.47 | -8.718 |
| EBIT 1 | -5.925 | -10.19 | -11.17 | -12.73 | -8.978 |
| Net income 1 | -8.962 | -10.25 | -11.1 | -12.5 | -10.49 |
| Net Debt 1 | -24.32 | -15.12 | -4.809 | -1.566 | -6.612 |
| Reference price 2 | 6,248.000 | 1,100.000 | 400.480 | 106.200 | 10.404 |
| Nbr of stocks (in thousands) | 10.9 | 11.1 | 11.3 | 24.1 | 244 |
| Announcement Date | 3/22/22 | 3/21/23 | 3/13/24 | 4/14/25 | 4/1/26 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 3.95M | |
| 22.53x | 8.66x | 14.4x | 0.94% | 2,903B | |
| 94.47x | 38.27x | 63.99x | -.--% | 307B | |
| 114.81x | 34.11x | 115.41x | 0.16% | 115B | |
| 85.68x | 17.2x | 37.52x | -.--% | 106B | |
| 168.24x | 9.75x | 24.89x | -.--% | 86.91B | |
| 412.49x | 17.77x | 71.55x | -.--% | 81.84B | |
| 27.3x | 1.39x | 10.77x | -.--% | 50.8B | |
| 122.79x | 4.5x | 22.93x | -.--% | 39.31B | |
| 96.45x | 5x | 24x | -.--% | 30.97B | |
| Average | 127.20x | 15.18x | 42.83x | 0.12% | 372.06B | |
| Weighted average by Cap. | 46.84x | 12.19x | 23.90x | 0.74% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ISPC Stock
- Valuation iSpecimen Inc.
Select your edition
All financial news and data tailored to specific country editions
